Will morphing boron-based inhibitors beat the β-lactamases?

The β-lactams remain the most important antibacterials, but their use is increasingly compromised by resistance, importantly by β-lactamases. Although β-lactam and non-β-lactam inhibitors forming stable acyl-enzyme complexes with nucleophilic serine β-lactamases (SBLs) are widely used, these are inc...

詳細記述

書誌詳細
主要な著者: Krajnc, A, Lang, P, Panduwawala, T, Brem, J, Schofield, C
フォーマット: Journal article
言語:English
出版事項: Elsevier 2019

類似資料